MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)

Name: MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)
License: Public Domain

Joachim Aerts, MD PhD

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic pancreatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230408
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.